Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aequus Pharmaceuticals Inc V.AQS

Alternate Symbol(s):  AQSZF

Aequus Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on developing and commercializing, differentiated products in ophthalmology. Its pipeline products include PAUL Glaucoma Implant, ZIMED PF, and REV-0100 / ReVision. PAUL is a glaucoma drainage device designed to regulate intraocular pressure in the patient’s eyes and prevent further progression of the disease. PAUL has introduced many design features and unified these into one device and offers a solution for patients with moderate to severe glaucoma. ZIMED PF is the first available multi-dose, preservative free, bimatoprost containing product in Canada. REV-0100 is in preclinical development as a treatment for Stargardt disease. REV-0100 works by reducing levels of a toxic lipid called lipid bisretinoid, which accumulates within the retina in material called lipofuscin.


TSXV:AQS - Post by User

Bullboard Posts
Comment by kuatoliveson Apr 03, 2017 3:43pm
170 Views
Post# 26069811

RE:No debts...

RE:No debts...
Stephanovich wrote: Allright with the ''no debts''.

But why did you loose 50% shares value in a year if this is a gold mine ?



Beacuse it wasn't worth 60+ cents a share at the time. A company will try and get maximum value for its bought financing regardless of whether or not it is a good deal for shareholders. It's the responsbility of the investor to guage the worth of the share price at a particular time. I got in at 28 cents because I thought the company was worth (or had the potential to be) more than 15M. My projections are for 60 cents in another year. Others may disagree, or want more return than that, but I'll take 100% return in a year any day.

Bullboard Posts